141 related articles for article (PubMed ID: 453877)
1. Plasmapheresis and immunosuppressive therapy. Effect on levels of intercellular antibodies in pemphigus vulgaris.
Auerbach R; Bystryn JC
Arch Dermatol; 1979 Jun; 115(6):728-30. PubMed ID: 453877
[TBL] [Abstract][Full Text] [Related]
2. Effect of plasmapheresis therapy on circulating levels of pemphigus antibodies.
Tan-Lim R; Bystryn JC
J Am Acad Dermatol; 1990 Jan; 22(1):35-40. PubMed ID: 2298963
[TBL] [Abstract][Full Text] [Related]
3. Pemphigus vulgaris. Combined treatment with intravenous corticosteroid pulse therapy, plasmapheresis, and azathioprine.
Fine JD; Appell ML; Green LK; Sams WM
Arch Dermatol; 1988 Feb; 124(2):236-9. PubMed ID: 3277542
[TBL] [Abstract][Full Text] [Related]
4. Synchronization of plasmapheresis and pulse cyclophosphamide therapy in pemphigus vulgaris.
Euler HH; Löffler H; Christophers E
Arch Dermatol; 1987 Sep; 123(9):1205-10. PubMed ID: 3632005
[TBL] [Abstract][Full Text] [Related]
5. [Trials with therapeutic plasmapheresis in pemphigus vulgaris].
Neppert J; Meissner K; Voigt H; Meigel W
Z Hautkr; 1980 Jun; 55(12):783-9. PubMed ID: 7415360
[TBL] [Abstract][Full Text] [Related]
6. [Plasmapheresis in the treatment of pemphigus].
Blaszczyk M; Chorzelski T; Daszynski J; Jabłońska S; Beutner EH
Z Hautkr; 1985 Aug; 60(15):1175-82. PubMed ID: 4049988
[TBL] [Abstract][Full Text] [Related]
7. Plasmapheresis therapy of pemphigus and bullous pemphigoid.
Roujeau JC
Semin Dermatol; 1988 Sep; 7(3):195-200. PubMed ID: 3153444
[TBL] [Abstract][Full Text] [Related]
8. Pathogenicity of the intercellular antibodies of pemphigus and their periodic removal from the circulation by plasmapheresis.
Ruocco V; Rossi A; Argenziano G; Aatarita C; Alviggi L; Farzati B; Papaleo G
Br J Dermatol; 1978 Feb; 98(2):237-41. PubMed ID: 629880
[TBL] [Abstract][Full Text] [Related]
9. Treatment of pemphigus with intravenous immunoglobulin.
Bystryn JC; Jiao D; Natow S
J Am Acad Dermatol; 2002 Sep; 47(3):358-63. PubMed ID: 12196744
[TBL] [Abstract][Full Text] [Related]
10. Plasma exchange in pemphigus. Uncontrolled study of ten patients.
Roujeau JC; Andre C; Joneau Fabre M; Lauret P; Flechet ML; Kalis B; Revuz J; Touraine R
Arch Dermatol; 1983 Mar; 119(3):215-21. PubMed ID: 6824359
[TBL] [Abstract][Full Text] [Related]
11. A case of pemphigus vulgaris successfully treated with single filtration plasmapheresis: a correlation of clinical disease activity with serum antibody levels.
Yano C; Ishiji T; Kamide R; Niimura M
J Dermatol; 2000 Jun; 27(6):380-5. PubMed ID: 10920583
[TBL] [Abstract][Full Text] [Related]
12. Autoantibodies to epithelial cells (intercellular substance) and their correlation with clinical activity of pemphigus vulgaris.
Golan D; Gilhar A; Shmuel Z; Moshkowitz M
Dermatologica; 1984; 169(6):339-41. PubMed ID: 6396110
[TBL] [Abstract][Full Text] [Related]
13. [Continuous plasma filtration. Experiences in the treatment of pemphigus vulgaris].
Vennemann F; Schedel A; Lorenzen M
Z Hautkr; 1984 Aug; 59(16):1075-9. PubMed ID: 6485455
[TBL] [Abstract][Full Text] [Related]
14. [Prolonged complete clinical remission in patients with severe pemphigus vulgaris after cycles of intravenous cyclophosphamide].
España Alonso A; Panizo C; Fernández S; Marquina M; Pretel M; Aguado L; Sánchez-Ibarrola A
Actas Dermosifiliogr; 2009 Mar; 100(2):113-20. PubMed ID: 19445875
[TBL] [Abstract][Full Text] [Related]
15. Double-filtration plasmapheresis combined with immunosuppressive treatment for severe pemphigus: 10 years' experience of a single center in China.
Liu Y; Zhang B; Ma J; Wang H; Fan X; Zheng K; Chen L; Li X; Qin Y; Li L; Li X
J Clin Apher; 2021 Feb; 36(1):20-27. PubMed ID: 32812668
[TBL] [Abstract][Full Text] [Related]
16. Successful use of cyclophosphamide and prednisone for initial treatment of pemphigus vulgaris.
Fellner MJ; Katz JM; McCabe JB
Arch Dermatol; 1978 Jun; 114(6):889-94. PubMed ID: 666324
[TBL] [Abstract][Full Text] [Related]
17. Invasive cutaneous aspergillosis complicating immunosuppressive therapy for recalcitrant pemphigus vulgaris.
Thakur BK; Bernardi DM; Murali MR; McClain SA; Clark RA
J Am Acad Dermatol; 1998 Mar; 38(3):488-90. PubMed ID: 9520034
[No Abstract] [Full Text] [Related]
18. Efficacy and safety of cyclophosphamide, azathioprine, and cyclosporine (ciclosporin) as adjuvant drugs in pemphigus vulgaris.
Olszewska M; Kolacinska-Strasz Z; Sulej J; Labecka H; Cwikla J; Natorska U; Blaszczyk M
Am J Clin Dermatol; 2007; 8(2):85-92. PubMed ID: 17428113
[TBL] [Abstract][Full Text] [Related]
19. Evaluating efficacy of plasmapheresis for patients with pemphigus using desmoglein enzyme-linked immunosorbent assay.
Nagasaka T; Fujii Y; Ishida A; Handa M; Tanikawa A; Amagai M; Nishikawa T
Br J Dermatol; 2008 Apr; 158(4):685-90. PubMed ID: 18241273
[TBL] [Abstract][Full Text] [Related]
20. The use of plasmapheresis and immunosuppression in the treatment of pemphigus vulgaris.
Turner MS; Sutton D; Sauder DN
J Am Acad Dermatol; 2000 Dec; 43(6):1058-64. PubMed ID: 11100023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
